Abstract:Abstact Background Novel compounds and more efficient treatment options are urgently needed for the treatment of non-small cell lung cancer (NSCLC). The decoction of Sophora flavescens has been used to treat NSCLC in the clinic, and matrine-type alkaloids are generally considered to be the key pharmacodynamic material basis. But the previous study showed that common matrine-type alkaloids exhibit significant cytotoxicity only when at concentrations close to the millimolar (mM) level. The key antitumor alkaloids in S. flavescens seem to have not yet been revealed. Purpose The aim of this study was to screen water-soluble matrine alkaloid with novel skeleton and enhanced activity from S. flavescens , and to reveal the pharmacological mechanism of its therapeutic effect on NSCLC. Methods Alkaloid was obtained from S. flavescens by chromatographic separation methods. The structure of alkaloid was determined by spectroscopic methods, and single-crystal X-ray diffraction. The mechanism of anti-NSCLC in vitro with cellular models was evaluated by MTT assay, western blotting, cell migration and invasion assay, plate colony-formation assay, tube formation assay, immunohistochemistry assay, hematoxylin and eosin staining. The antitumor efficacy in vivo was test in NSCLC xenograft models. Results A novel water-soluble matrine-derived alkaloid incorporating 6/8/6/6 tetracyclic ring system, named sophflarine A (SFA), was isolated from the roots of S. flavescens . SFA had significantly enhanced cytotoxicity compared with the common matrine-type alkaloids, having an IC 50 value of 11.3 μM in A549 and 11.5 μM in H820 cells at 48h. Mechanistically, SFA promoted NSCLC cell death by inducing pyroptosis via activating the NLRP3/caspase-1/GSDMD signaling pathway, and inhibited cancer cell proliferation by increasing the ROS production to activate autophagy via blocking the PI3K/AKT/mTOR signaling pathway. Additionally, SFA also inhibited NSCLC cell migration and invasion by suppressing EMT pathway, and inhibited cancer cell colony formation and human umbilical vein endothelial cell angiogenesis. In concordance with the above results, SFA treatment blocked tumor growth in an A549 cell-bearing orthotopic mouse model. Conclusion This study revealed a potential therapeutic mechanism of a novel matrine-derived alkaloid, which not only described a rational explanation for the clinical utilization of S. flavescens , but also provided a potential candidate compound for NSCLC treatment.

Sophoridine Inhibits the Tumour Growth of Non-Small Lung Cancer by Inducing Macrophages M1 Polarisation via MAPK-Mediated Inflammatory Pathway

Sophoridine suppresses macrophage-mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8+ T cytotoxic function against gastric cancer

Sophoridine Inhibits Lung Cancer Cell Growth and Enhances Cisplatin Sensitivity Through Activation of the P53 and Hippo Signaling Pathways.

Sophoridine Exerts Tumor-Suppressive Activities Via Promoting ESRRG-mediated Β-Catenin Degradation in Gastric Cancer

Sophoridine Suppresses Cell Growth in Human Medulloblastoma Through FoxM1, NF-κB and AP-1.

Sophoridine Inhibits Human Colorectal Cancer Progression Via Targeting MAPKAPK2

Sophoridine is a New Antitumor Medicine with New Molecular Structure

Sophoridine Antiproliferative Effects in Human Thyroid Carcinoma Cells Mediated by Regulating PI3K/AKT/m-TOR Signalling Pathway

Sophoridine Derivatives Induce Apoptosis and Autophagy to Suppress the Growth of Triple‐Negative Breast Cancer through Inhibition of mTOR Signaling

Sophoridine Inhibits Proliferation and Induces Apoptosis Through Downregulation of FoxM1 in Human Adenocarcinoma from Esophagogastric Junction

Trans-3, 5, 4′-trimethoxystilbene restrains non-small-cell lung carcinoma progression via suppressing M2 polarization through inhibition of m6A modified circPACRGL-mediated Hippo signaling

Β-Elemene Inhibits Tumor-Promoting Effect of M2 Macrophages in Lung Cancer.

Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy

Sophoridine inhibits endotoxin‐induced acute lung injury by enhancing autophagy of macrophage and reducing inflammation

Sophoridine: A review of its pharmacology, pharmacokinetics and toxicity

Sophoridine Inhibited Epithelial-Mesenchymal Transition, Migration and Invasion in Colorectal Cancer Via Regulating ZO-1 and CCND1 Expressions

Sophoridine-loaded PLGA Microspheres for Lung Targeting: Preparation, in Vitro, and in Vivo Evaluation

Network pharmacology and in vitro experiments reveal sophoridine‐induced apoptosis and G1 phase arrest via ROS‐dependent PI3K/Akt/FoxO3a pathway activation in human bladder cancer cells

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

The Anti-Lung Cancer Activity of SEP is Mediated by the Activation and Cytotoxicity of NK Cells Via TLR2/4 in Vivo.